Press release
CD BioSciences Launches Innovative Immune System Tissue Microarrays for Research Usage
CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is excited to announce the launch of its new Immune System Tissue Microarrays [https://www.bioimagingtech.com/immune-system-tissue-microarrays.html] for the scientific community to study the complex interactions of the immune system in various tissues. These innovative products offer researchers a powerful tool to unravel the complexities of the immune system and accelerate the development of new therapies.
Tissue microarray is a recent innovation in the field of pathology. This versatile technology for automated data analysis facilitates retrospective and prospective human tissue studies. It is a practical and effective tool for high-throughput molecular analysis of tissues, helping to identify new diagnostic and prognostic markers and targets for human cancers, with a wide range of potential applications in basic research, tumor prognosis and drug discovery.
Immune System Tissue Microarrays from CD BioSciences are meticulously designed to feature a variety of tissue cores, allowing researchers to simultaneously analyze the expression of multiple immune markers in a variety of tissues and providing invaluable information for understanding the distribution, function and interactions of immune cells. These tissue microarrays offer unparalleled efficiency, reproducibility, and versatility, making them an essential asset for advancing immunology research.
For example, the Lymphoma with Normal Tissue Microarray (Catalog NO. IMCT024) is a valuable resource for researchers studying lymphoma. This comprehensive collection includes 192 cases of lymphoma and normal tissue, organized into 96 core samples. It's designed for use in various histological techniques such as immunohistochemistry (IHC) and in situ hybridization (ISH), and other routine procedures.
The microarray offers a diverse range of lymphoma subtypes, including diffuse B-cell lymphoma, Burkitt lymphoma, follicular lymphoma, Hodgkin's lymphoma, Lennart lymphoma, mucosa-associated lymphoma, anaplastic large cell lymphoma, angio-immunoblastoid lymphadenopathy T-cell lymphoma, T-cell lymphoma, plasma cell lymphoma, and normal lymph node tissue. Each case is represented by duplicate nuclear cores, providing ample material for analysis.
In addition, the Non-Hodgkin's Lymphoma Tissue Microarray 4, 80 Cases, 42 Cores (Catalog NO. IMCT038) is a microarray focused on non-Hodgkin's lymphoma tissues that can be applied in IHC, ISH and other routine histology procedures. The microarray includes a diverse range of non-Hodgkin's lymphoma subtypes, including B-cell lymphoma, B small non-cleaved cell lymphoma, large B-cell lymphoma, B large cleaved cell lymphoma, B large non-cleaved cell lymphoma, B small cleaved cell lymphoma, mucosa-associated B-cell lymphoma, T-cell lymphoma, lymphocytic plasmacytoid lymphoma, and anaplastic large cell lymphoma. Each case of lymphoma in the microarray has duplicate cores, while there are 3 cases of normal lymph node tissue and 1 case of placenta tissue, each with a single core.
CD BioSciences is dedicated to providing researchers with the highest quality tools and services to advance their scientific endeavors. These cutting-edge Immune System Tissue Microarrays offer researchers a comprehensive and efficient solution to accelerate their immune system research. For more information about the products and other custom solutions from CD BioSciences, please visit https://www.bioimagingtech.com/immune-system-tissue-microarrays.html.
About CD BioSciences
CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to image cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules.
Media Contact
Company Name: CD BioSciences
Contact Person: Michelle Moser
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-biosciences-launches-innovative-immune-system-tissue-microarrays-for-research-usage]
State: New York
Country: United States
Website: https://www.bioimagingtech.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD BioSciences Launches Innovative Immune System Tissue Microarrays for Research Usage here
News-ID: 3671100 • Views: …
More Releases from ABNewswire
Prince Shizzy Unveils New Single "Desire" Set for Release on October 1
Prince Shizzy is happy to announce his new single 'Desire' which is all set to release on 1st October, 2024
Image: https://www.abnewswire.com/uploads/647b7818c346879d4abbce6a30261199.jpg
Prince Shizzy, a talented Afrobeat singer-songwriter and producer originally based in the United States, is set to captivate audiences with the release of his highly anticipated new single, "Desire," on October 1.
Known for his infectious rhythms and soulful melodies, Prince Shizzy brings a unique sound that resonates with fans of…
Maximize Solar Setup with Oukitel's Solar Panel Extension Cables for Portable Ge …
Oukitel , a leading brand in portable power solutions, is proud to announce its latest addition to the solar power accessory lineup: the Solar Panel Extension Cables [https://eu.oukitel.com/products/oukitel-solar-extension-cable ]. These cables are designed to enhance the performance and versatility of portable solar generators, providing users with increased flexibility and efficiency in capturing solar energy.
As the demand for off-grid power continues to grow, the need for adaptable and scalable solutions has…
STEMart Introduces Advanced Accelerated Aging Testing Services for Medical Devic …
STEMart launches new Accelerated Aging Testing Services for medical device manufacturers.
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the launch of its new Accelerated Aging Testing [https://www.ste-mart.com/accelerate-aging-testing.htm] Services for medical device manufacturers to ensure the long-term reliability and safety of their products.
The Accelerated Aging Testing utilizes high temperatures for a period of time to simulate the effects of real-time aging, artificially accelerating…
Apollonia Fassett-McDonald Releases Powerful New Book
My Silent Cry, Chronicling Her Journey of Survival and Healing
Lillington, North Carolina - Apollonia Fassett-McDonald, a survivor of trauma and a symbol of hope for many, proudly announces the release of her deeply personal and inspiring new book, My Silent Cry. This gripping memoir offers readers a raw and unfiltered glimpse into the harrowing experiences of Fassett-McDonald's childhood and the long path she has walked toward healing.
My Silent Cry is…
More Releases for BioSciences
Batten Disease Treatment Market Overall Study Report 2022-2028 | Seneb BioScienc …
Coherent Market Insights has released a new research study on the "Batten Disease Treatment Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Batten Disease Treatment Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report. The Batten Disease Treatment Market research report…
Antibody Humanization Market to Witness Huge Growth by Key Players: Accurus Bios …
ReportsnReports publishes the report titled Antibody Humanization that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,…
Bruton's Tyrosine Kinase (Btk) Inhibitors Market 2020-2027 | Leading Players: Ab …
Worldwide Market Reports adds "Bruton's Tyrosine Kinase (Btk) Inhibitors Market 2020 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2027" reports to its database.
This report provides in depth study of "Bruton's Tyrosine Kinase (Btk) Inhibitors Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Bruton's Tyrosine Kinase (Btk) Inhibitors Market report also provides an in-depth survey of key players in the market which…
Batten Disease Treatment Market Key companies Profile Like Seneb BioSciences,Bio …
Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of…
Batten Disease Treatment Market Trends, Research And Projections For 2018-2026 | …
Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of…
Batten Disease Treatment Market Competitive Analysis are Seneb BioSciences, Inc. …
According to the Centers for Disease Control and Prevention (CDC), Batten disease is observed in 2-4 per 100,000 live births in the United States on an average. The Batten disease although is rare but has high incidence rates in Finland, Sweden, and other parts of the Europe as compared to rest of the world. According to the Batten Disease Support and Research Association, the batten disease has often been encountered…
